These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 11103436)
21. The Fas signalling pathway and its role in the pathogenesis of cancer. Houston A; O'Connell J Curr Opin Pharmacol; 2004 Aug; 4(4):321-6. PubMed ID: 15251123 [TBL] [Abstract][Full Text] [Related]
22. Regulation of Fas (CD95)-induced apoptotic and necrotic cell death by reactive oxygen species in macrophages. Medan D; Wang L; Toledo D; Lu B; Stehlik C; Jiang BH; Shi X; Rojanasakul Y J Cell Physiol; 2005 Apr; 203(1):78-84. PubMed ID: 15368542 [TBL] [Abstract][Full Text] [Related]
24. The role of apoptosis in thyroid disease. Tsatsoulis A Minerva Med; 2002 Jun; 93(3):169-80. PubMed ID: 12094148 [TBL] [Abstract][Full Text] [Related]
25. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. Acosta-Rodríguez EV; Craxton A; Hendricks DW; Merino MC; Montes CL; Clark EA; Gruppi A Eur J Immunol; 2007 Apr; 37(4):990-1000. PubMed ID: 17357108 [TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
27. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome). Paquet P; Piérard GE; Quatresooz P Int Arch Allergy Immunol; 2005 Mar; 136(3):205-16. PubMed ID: 15713983 [TBL] [Abstract][Full Text] [Related]
28. The role of Fas and FasL as mediators of anticancer chemotherapy. Poulaki V; Mitsiades CS; Mitsiades N Drug Resist Updat; 2001 Aug; 4(4):233-42. PubMed ID: 11991678 [TBL] [Abstract][Full Text] [Related]
29. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease. Georgantas RW; Bohana-Kashtan O; Civin CI Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590 [TBL] [Abstract][Full Text] [Related]
30. Cell death modulation by intravenous immunoglobulin. von Gunten S; Simon HU J Clin Immunol; 2010 May; 30 Suppl 1():S24-30. PubMed ID: 20405180 [TBL] [Abstract][Full Text] [Related]
31. Toxic epidermal necrolysis: review of pathogenesis and management. Downey A; Jackson C; Harun N; Cooper A J Am Acad Dermatol; 2012 Jun; 66(6):995-1003. PubMed ID: 22169256 [TBL] [Abstract][Full Text] [Related]
32. Graft-versus-host reaction manifested as toxic epidermal necrolysis in a patient with acute leukemia. Berkel AI; Tinaztepe K Turk J Pediatr; 1981; 23(1):37-41. PubMed ID: 7200649 [No Abstract] [Full Text] [Related]
33. Inhibition of Fas death pathway in cytotoxic T cells: an approach to prevent graft-versus-host disease. Paillard F Hum Gene Ther; 1998 Jul; 9(11):1528-9. PubMed ID: 9694151 [No Abstract] [Full Text] [Related]